Franklin Resources
RCUS icon

Franklin Resources’s Arcus Biosciences RCUS Stock Holding History

Franklin Resources’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-853,491
Closed -$20.3M – 3277
2025
Q4 		$20.3M Buy
+853,491
New +$17.4M 0.01% 951
2022
Q2 		– Sell
-755,755
Closed -$23.9M – 2444
2022
Q1 		$23.9M Sell
755,755
-427,766
-36% -$14.3M 0.01% 812
2021
Q4 		$47.9M Sell
1,183,521
-273,828
-19% -$10.6M 0.02% 646
2021
Q3 		$50.8M Buy
1,457,349
+581,311
+66% +$18.1M 0.02% 654
2021
Q2 		$24.1M Buy
876,038
+81,216
+10% +$2.32M 0.01% 820
2021
Q1 		$22.3M Buy
794,822
+64,800
+9% +$2.25M 0.01% 814
2020
Q4 		$19M Buy
730,022
+22
+0% +$533 0.01% 822
2020
Q3 		$12.5M Hold
730,000
– – 0.01% 862
2020
Q2 		$17.2M Buy
730,000
+275,000
+60% +$7.42M 0.01% 765
2020
Q1 		$6.32M Buy
+455,000
New +$5.66M ﹤0.01% 891

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Franklin Resources's RCUS Position: Q1 2026 in Review

Franklin Resources sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 853,491 shares — an estimated $20.3M sold.

Franklin Resources first reported a position in RCUS in Q1 2020 and held it in 10 quarters. The position peaked at $50.8M in Q3 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Franklin Resources reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • Franklin Resources sold 853,491 Arcus Biosciences shares in Q1 2026, an estimated $20.3M.
  • Franklin Resources first reported a position in Arcus Biosciences in Q1 2020 and held it in 10 quarters.
  • Franklin Resources's Arcus Biosciences position peaked at $50.8M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.